ArticlePathology oncology research : POR2021

Using Patient-Derived Xenografts to Explore the Efficacy of Treating Head-and-Neck Squamous Cell Carcinoma With Anlotinib.

Fangling Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.